Cargando…

Promoter Methylation Status and Expression Levels of RASSF1A Gene in Different Phases of Acute Lymphoblastic Leukemia (ALL)

Background: Although the precise pathogenesis of acute lymphoblastic leukemia (ALL) remains unclear, studying gene-regulating mechanisms during ALL pathogeneses may shed light on the underlying mechanisms driving malignant behavior. There is some evidence showing the promoter hypermethylation and si...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sohani, Mahsa, Rostami, Shahrbano, Azad, Mehdi, Hojjatipour, Tahereh, Chahardouli, Bahram, Alizadeh, Shaban
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tehran University of Medical Sciences. 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885129/ https://www.ncbi.nlm.nih.gov/pubmed/33613896 http://dx.doi.org/10.18502/ijhoscr.v15i1.5245

Ejemplares similares

Aberrant DNA Methylation Status and mRNA Expression Level of SMG1 Gene in Chronic Myeloid Leukemia: A Case-Control Study
por: Hojjatipour, Tahereh, et al.
Publicado: (2022)

Identification of lncRNAs associated with the progression of acute lymphoblastic leukemia using a competing endogenous RNAs network
por: NEKOEIAN, SHAHRAM, et al.
Publicado: (2023)

Study of SFRP1 and SFRP2 methylation status in patients with de novo Acute Myeloblastic Leukemia
por: Ghasemi, Ali, et al.
Publicado: (2015)

Patterns of DNMT1 Promoter Methylation in Patients with Acute Lymphoblastic Leukemia
por: Rahmani, Tirdad, et al.
Publicado: (2017)

Aberrant Methylation of APAF-1 Gene in Acute Myeloid Leukemia Patients
por: Rostami, Shahrbano, et al.
Publicado: (2017)

Concurrent Evaluation of the Expression and Methylation of secreted frizzled-related protein 2 along with beta-catenin Expression in Patients with non-M3 Acute Myeloid Leukemia
por: Mirzaeyan, Fatemeh, et al.
Publicado: (2021)

Evaluation of Minimal Residual Disease in Acute Myeloid Leukemia with NPM1 Marker
por: Alizad Ghandforoush, Nasrin, et al.
Publicado: (2016)

The impact of ICAM-1, CCL2 and TGM2 gene polymorphisms on differentiation syndrome in acute promyelocytic leukemia
por: Mohammadzadeh, Zahra, et al.
Publicado: (2021)

PB2178: EVALUATION OF JAK2 EXON 12 MUTATIONS IN PATIENTS WITH JAK2 (V617F)-NEGATIVE POLYCYTHEMIA VERA
por: Khosravi, Sahar, et al.
Publicado: (2023)

Frequency of M287T/AS3MT Single Nucleotide Polymorphism in an Iranian Population
por: Farhid, Fatemeh, et al.
Publicado: (2017)

Curcumin Combined with Thalidomide Reduces Expression of STAT3 and Bcl-xL, Leading to Apoptosis in Acute Myeloid Leukemia Cell Lines
por: Mohammadi Kian, Mahnaz, et al.
Publicado: (2020)

Sensitivity to Pain in Children With Acute Lymphoblastic Leukemia (ALL)
por: Firoozi, Manijeh, et al.
Publicado: (2012)

FLT3-ITD Compared with DNMT3A R882 Mutation Is a More Powerful Independent Inferior Prognostic Factor in Adult Acute Myeloid Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study
por: Ardestani, Majid Teremmahi, et al.
Publicado: (2018)

The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma
por: Djos, Anna, et al.
Publicado: (2012)

A Single Center Study of Prescribing and Treatment Outcomes of Patients with Chronic Myeloid Leukemia
por: Nekoohesh, Ladan, et al.
Publicado: (2020)

Integrated genomic sequencing in myeloid blast crisis chronic myeloid leukemia (MBC-CML), identified potentially important findings in the context of leukemogenesis model
por: Kazemi-Sefat, Golnaz Ensieh, et al.
Publicado: (2022)

Author Correction: Integrated genomic sequencing in myeloid blast crisis chronic myeloid leukemia (MBC-CML), identified potentially important findings in the context of leukemogenesis model
por: Kazemi‑Sefat, Golnaz Ensieh, et al.
Publicado: (2023)

Reciprocal Interactions of Leukemic Cells with Bone Marrow Stromal Cells Promote Enrichment of Leukemic Stell Cell Compartments in Response to Curcumin and Daunorubicin
por: Mohammadi, Saeed, et al.
Publicado: (2017)

Incidence and Prognostic Impact of WT-1 Gene Exon7 and 9 Mutations in Acute Promyelocytic Leukemia
por: Nejatifar, Fatemeh, et al.
Publicado: (2022)

Promoter DNA Methylation Frequency and Clinicopathological Role of miR-129-2 Gene in Patients with Chronic Lymphocytic Leukemia
por: Hashemi, Morteza, et al.
Publicado: (2020)

Expression of Long Non-Coding RNA H19 in Acute Lymphoblastic Leukemia
por: Asadi, Marjan, et al.
Publicado: (2023)

A Comparative Study of the Bone Marrow- and Umbilical Cord-Derived Mesenchymal Stem Cells (MSCs) Efficiency on Generating MSC-Educated Macrophages (MEMs)
por: Shirin, Mahsa, et al.
Publicado: (2022)

Predictive value of the serum RASSF10 promoter methylation status in gastric cancer
por: Hu, Yilin, et al.
Publicado: (2019)

The Role of RASSF1A Methylation in Cancer
por: Hesson, Luke B., et al.
Publicado: (2007)

Spontaneous Complete Remission of Acute Myeloid Leukemia in the Absence of Disease-Modifying Therapy following Severe Pulmonary Involvement by Coronavirus Infectious Disease-19
por: Barkhordar, Maryam, et al.
Publicado: (2022)

Multi-Omics Analysis of Acute Lymphoblastic Leukemia Identified the Methylation and Expression Differences Between BCP-ALL and T-ALL
por: Li, Jin-Fan, et al.
Publicado: (2021)

Minimal Residual Disease Detection Using Gene Scanning Analysis, Fluorescent Fragment Analysis, and Capillary Electrophoresis for IgH Rearrangement in Adult B-Lineage Acute Lymphoblastic Leukemia: A Cross-Sectional Study
por: Shahkarami, Sepideh, et al.
Publicado: (2023)

Combined RASSF1A and RASSF2A Promoter Methylation Analysis as Diagnostic Biomarker for Bladder Cancer
por: Meng, Wei, et al.
Publicado: (2012)

RASSF1A Site-Specific Methylation Hotspots in Cancer and Correlation with RASSF1C and MOAP-1
por: Volodko, Natalia, et al.
Publicado: (2016)

Inhibitory Effects of Arsenic Trioxide and Thalidomide on Angiogenesis and Vascular Endothelial Growth Factor Expression in Leukemia Cells
por: Kian, Mahnaz Mohammadi, et al.
Publicado: (2018)

Pericardial Relapse of Acute Lymphoblastic Leukemia (ALL)
por: Maslov, Diana V., et al.
Publicado: (2021)

Methylation and Expression Status of The CpG-Island of SMG1 Promoter in Acute Myeloid Leukemia: A Follow-Up Study in Patients
por: Karami, Neda, et al.
Publicado: (2022)

RASSF6; the Putative Tumor Suppressor of the RASSF Family
por: Iwasa, Hiroaki, et al.
Publicado: (2015)

Methylation-associated down-regulation of RASSF1A and up-regulation of RASSF1C in pancreatic endocrine tumors
por: Malpeli, Giorgio, et al.
Publicado: (2011)

Impact of RASSF1A gene methylation on the metastatic axillary nodal status in breast cancer patients
por: Jezkova, Eva, et al.
Publicado: (2017)

Clinical utility of RASSF1A methylation in human malignancies
por: Grawenda, A M, et al.
Publicado: (2015)

Methylation Dynamics of RASSF1A and Its Impact on Cancer
por: Malpeli, Giorgio, et al.
Publicado: (2019)

The RASSF1 Gene and the Opposing Effects of the RASSF1A and RASSF1C Isoforms on Cell Proliferation and Apoptosis
por: Reeves, Mark E., et al.
Publicado: (2013)

RASSF10 suppresses hepatocellular carcinoma growth by activating P53 signaling and methylation of RASSF10 is a docetaxel resistant marker
por: Jin, Yongshuai, et al.
Publicado: (2015)

Methylation of HIN-1, RASSF1A, RIL and CDH13 in breast cancer is associated with clinical characteristics, but only RASSF1A methylation is associated with outcome
por: Xu, Jia, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_kpr8kkb748ro88e6go9fuj716k